4//SEC Filing
Hall Ashley 4
Accession 0001209191-22-061038
CIK 0001637715other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 6:11 PM ET
Size
9.4 KB
Accession
0001209191-22-061038
Insider Transaction Report
Form 4
Hall Ashley
Chief Development Officer
Transactions
- Award
Stock option (right to buy)
2022-12-09+125,000→ 125,000 totalExercise: $1.80Exp: 2032-12-08→ Common Stock (125,000 underlying)
Holdings
- 35,600
Common Stock
Footnotes (2)
- [F1]Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on June 8, 2022 and 4,000 shares acquired under the Plan on December 8, 2022.
- [F2]The shares vest in a series of 16 equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001801842
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 6:11 PM ET
- Size
- 9.4 KB